USP 795 Compounding Standards for Ketamine Troches

What USP 795 Means for Ketamine Troches

USP 795 is the compounding quality standard your pharmacy should be following if it prepares your ketamine troches. USP (United States Pharmacopeia) is a nonprofit organization that sets official quality standards for medicines compounded and dispensed in the United States, and USP General Chapter 795, "Pharmaceutical Compounding, Nonsterile Preparations," is the chapter that applies to troches because they're mixed, molded, and dispensed as nonsterile lozenges rather than manufactured by a drug company. The standard covers facility cleanliness, staff training, ingredient sourcing, documentation, and beyond-use dating (BUD), the pharmacy-assigned date after which a compounded preparation shouldn't be used, based on formulation and stability rather than FDA testing. Most state boards of pharmacy incorporate USP compounding chapters into their licensing rules, which is what makes USP 795 compliance a practical, checkable signal of pharmacy quality, separate from FDA approval, which compounded ketamine troches don't have. Read more about the fda status of compounded ketamine troches before you evaluate a pharmacy.

What USP 795 Actually Requires

USP 795 breaks nonsterile compounding into categories that a pharmacy must document for each batch of ketamine troches it prepares. A pharmacy following the standard should be able to describe, on request, its practices covering the following:

• Facility and equipment controls: a designated compounding area, calibrated scales and molds, and cleaning logs that keep cross-contamination risk low.
• Personnel training and competency checks: staff who compound troches complete initial and periodic hand-hygiene, garbing, and technique evaluations under USP 795 before compounding independently.
• Component and ingredient verification: certificates of analysis for the active ingredients in ketamine troches and any inactive ingredients, confirming source, purity, and expiration.
• Master formulation and compounding records: a written recipe and a batch-specific record for every formulation and strength, so a specific troche can be traced back to its ingredients and preparation date.
• Beyond-use dating (BUD): a documented rationale for how long the troche is considered stable and safe to use, whether that's a conservative default limit or a longer date supported by the pharmacy's own stability testing.

These records don't usually ship with your prescription, but a legitimate compounding pharmacy should be willing to describe its process and answer direct questions about it. This is educational information, not medical advice, your prescriber and pharmacist are the right people to confirm details about your specific troche.

503A vs. 503B: Who's Actually Making Your Troches

Most ketamine troches come from a 503A compounding pharmacy, a pharmacy that compounds a specific formulation for an individual patient after receiving a valid prescription, operating primarily under state board of pharmacy oversight plus USP standards. A 503B outsourcing facility, by contrast, registers directly with the FDA under the Drug Quality and Security Act and compounds in larger batches without a patient-specific prescription, following FDA current Good Manufacturing Practice (cGMP) rules instead of USP 795. If your prescriber sends your prescription to a named pharmacy that fills it specifically for you, you're almost certainly dealing with a 503A pharmacy governed by USP 795 and your state board of pharmacy.

Ketamine is not currently included on the National Institute for Occupational Safety and Health's (NIOSH) hazardous drug list, so USP General Chapter 800, which governs handling of hazardous drugs, typically doesn't add extra compounding requirements for troches the way it would for a chemotherapy agent. That said, individual pharmacies can apply additional precautions, and lists can be revised, so this isn't something to assume without checking the current NIOSH list or asking the pharmacy directly.

The pharmacy side also shapes what you'll notice in the finished product, see what do ketamine troches look like, how formulation choices affect onset and duration of ketamine troches, and the difference between sublingual vs buccal administration. For broader safety context, see the ketamine troche safety guide.